Coston McIsaac & Partners’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6K Sell
97
-1
-1% -$74 ﹤0.01% 667
2025
Q4
$7K Sell
98
-38
-28% -$2.91K ﹤0.01% 626
2025
Q3
$9K Hold
136
﹤0.01% 565
2025
Q2
$10K Buy
136
+1
+0.7% +$71 ﹤0.01% 530
2025
Q1
$10K Sell
135
-1
-0.7% -$74 ﹤0.01% 502
2024
Q4
$8K Hold
136
﹤0.01% 531
2024
Q3
$9 Hold
136
﹤0.01% 525
2024
Q2
$7K Buy
+136
New +$8.26K ﹤0.01% 527

Other funds holding SOLV

Coston McIsaac & Partners's SOLV Position: Q1 2026 in Review

Coston McIsaac & Partners reduced its Solventum (SOLV) stake by 1% in Q1 2026, selling an estimated $74 and leaving 97 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #667.

Coston McIsaac & Partners first reported a position in SOLV in Q2 2024 and has held it in 8 quarters since. The position peaked at $10K in Q2 2025. 879 funds tracked by Wall St. Rank hold SOLV as of Q1 2026.

  • Coston McIsaac & Partners held 97 shares of Solventum worth $6K as of Q1 2026.
  • Coston McIsaac & Partners sold 1 Solventum share in Q1 2026, an estimated $74.
  • Solventum made up ﹤0.01% of Coston McIsaac & Partners's portfolio in Q1 2026, its #667 holding.
  • Coston McIsaac & Partners first reported a position in Solventum in Q2 2024 and has held it in 8 quarters since.
  • Coston McIsaac & Partners's Solventum position peaked at $10K in Q2 2025.
  • 879 funds tracked by Wall St. Rank held Solventum as of Q1 2026.

Based on Coston McIsaac & Partners's 13F filing for Q1 2026, filed 22 Apr 2026.